No industry is growing faster than cannabis. It’s poised to disrupt alcohol, tobacco, pharmaceuticals, supplements and health. Investors stand to make a fortune as pot stocks soar and the industry rises to a projected $1 trillion globally.
I Traded In Opioids for Cannabis – and Never Looked Back
Medical cannabis can serve as a replacement for opioid prescriptions and other pain relief drugs.
3 Major Roadblocks for Cannabis Companies
Although cannabis legalization has been expanding across the country, pot is still federally illegal… which has created big issues for the industry.
Is the End of Cannabis Prohibition Here?
The federal legalization of cannabis is closer than ever since the U.S. House of Representatives passed the SAFE Banking Act.
In the Weeds on 4/20: History, Trends, Myths and More
In celebration of the 50th anniversary of 4/20, here are some fun facts about the cannabis holiday and how it began.
Top 3 Cannabis ETFs to Profit From Expanded Legalization
These cannabis ETFs are one-stop shops for some of the best companies in the industry.
High Times Are Here for Cannabis Companies and Investors
As more states approve adult-use legislation, the federal legalization of cannabis in the U.S. looms closer.
American Cannabis Companies See More Revenue Than Canadian LPs
Though investors are usually more familiar with Canadian cannabis companies, American producers take the cake in revenue.
This $120 Billion Opportunity Is the Next Frontier for Cannabis
The largest cannabis company in the United States is beginning to expand its business to Europe.
What to Expect From the U.S. Cannabis Market in 2021
Here’s what lies ahead for the cannabis market after its monumental rebound in 2020.